Recursion Pharmaceuticals (RXRX) Insider Trading & Ownership $6.91 -0.41 (-5.60%) (As of 11/14/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Recursion Pharmaceuticals (NASDAQ:RXRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage15.75%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$10.25 M Get RXRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Recursion Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RXRX Insider Buying and Selling by Quarter Ad Crypto 101 MediaMusk Says ‘Dollar Will Be Worth Nothing…’Cash In On the Pro-Crypto America 27 experts reveal their top picks for 2025 Click here to reserve your seat at the Crypto Community Summit. Recursion Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/29/2024Blake BorgesonDirectorSell11,447$6.72$76,923.84 10/24/2024Tina MarriottCOOSell6,000$6.31$37,860.00 10/15/2024Blake BorgesonDirectorSell11,447$6.67$76,351.49 10/8/2024Michael SecoraCFOSell15,000$6.32$94,800.00 10/2/2024Christopher GibsonCEOSell20,000$6.16$123,200.00 10/1/2024Blake BorgesonDirectorSell11,447$6.22$71,200.34 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/26/2024Tina MarriottCOOSell6,000$7.00$42,000.00 9/17/2024Blake BorgesonDirectorSell11,447$6.84$78,297.48 9/10/2024Michael SecoraCFOSell15,000$6.17$92,550.00 9/4/2024Christopher GibsonCEOSell20,000$6.04$120,800.00 9/3/2024Blake BorgesonDirectorSell11,447$6.27$71,772.69 8/29/2024Tina MarriottCOOSell6,000$7.56$45,360.00 8/20/2024Blake BorgesonDirectorSell11,447$7.12$81,502.64 8/13/2024Michael SecoraCFOSell15,000$6.35$95,250.00 8/7/2024Christopher GibsonCEOSell30,000$7.10$213,000.00 8/6/2024Blake BorgesonDirectorSell11,447$6.82$78,068.54 7/25/2024Tina MarriottCOOSell6,000$8.13$48,780.00 7/23/2024Blake BorgesonDirectorSell11,447$8.48$97,070.56 7/10/2024Christopher GibsonCEOSell50,000$7.48$374,000.00 7/9/2024Blake BorgesonDirectorSell11,447$7.32$83,792.04 7/9/2024Michael SecoraCFOSell15,000$7.32$109,800.00 6/27/2024Tina MarriottCOOSell6,000$7.21$43,260.00 6/25/2024Blake BorgesonDirectorSell11,447$9.51$108,860.97 6/13/2024Michael SecoraCFOSell15,000$9.32$139,800.00 6/11/2024Blake BorgesonDirectorSell11,447$8.45$96,727.15 6/5/2024Christopher GibsonCEOSell50,000$8.42$421,000.00 5/30/2024Tina MarriottCOOSell3,000$8.78$26,340.00 5/28/2024Blake BorgesonDirectorSell11,447$9.17$104,968.99 5/1/2024Christopher GibsonCEOSell50,000$7.73$386,500.00 4/30/2024Blake BorgesonDirectorSell11,447$7.95$91,003.65 4/25/2024Tina MarriottCOOSell3,000$7.67$23,010.00 4/17/2024Michael SecoraCFOSell23,124$7.58$175,279.92 4/16/2024Blake BorgesonDirectorSell11,447$7.66$87,684.02 4/3/2024Christopher GibsonCEOSell40,000$8.84$353,600.00 4/2/2024Blake BorgesonDirectorSell11,447$8.82$100,962.54 3/28/2024Christopher GibsonCEOSell40,000$10.10$404,000.00 3/21/2024Tina MarriottCOOSell8,000$10.75$86,000.00 3/19/2024Blake BorgesonDirectorSell20,054$10.79$216,382.66 3/13/2024Michael SecoraCFOSell25,000$11.03$275,750.00 3/6/2024Christopher GibsonCEOSell36,319$11.86$430,743.34 The next assassination attempt won’t be on Trump (Ad)President Trump is soon to be back in the White House. Unity has been restored to the U.S. But if you watched the President’s 25-minute victory speech, you probably noticed he spent nearly four minutes speaking about one very controversial person.I share with you in this special investigative documentary.3/5/2024Blake BorgesonDirectorSell20,054$12.06$241,851.24 2/22/2024Tina MarriottCOOSell8,000$14.89$119,120.00 2/20/2024Blake BorgesonDirectorSell20,054$12.32$247,065.28 2/13/2024Michael SecoraCFOSell25,000$9.86$246,500.00 2/7/2024Christopher GibsonCEOSell48,272$9.22$445,067.84 2/6/2024Blake BorgesonDirectorSell11,447$9.30$106,457.10 1/25/2024Tina Marriott LarsonCOOSell8,000$10.35$82,800.00 1/23/2024Blake BorgesonDirectorSell20,054$10.58$212,171.32 1/16/2024Michael SecoraCFOSell25,000$10.45$261,250.00 1/16/2024Shafique ViraniInsiderSell18,000$10.93$196,740.00 1/9/2024Dean Y LiDirectorSell29,000$13.66$396,140.00 1/3/2024Christopher GibsonCEOSell30,853$9.49$292,794.97 12/26/2023Blake BorgesonDirectorSell20,054$10.63$213,174.02 12/15/2023Shafique ViraniInsiderSell18,000$9.60$172,800.00 12/14/2023Zavain DarDirectorSell20,141$9.00$181,269.00 12/12/2023Blake BorgesonDirectorSell11,447$7.40$84,707.80 12/12/2023Michael SecoraCFOSell25,000$7.39$184,750.00 12/6/2023Christopher GibsonCEOSell59,829$7.49$448,119.21 11/28/2023Blake BorgesonDirectorSell11,447$6.72$76,923.84 11/16/2023Tina Marriott LarsonCOOSell3,000$6.76$20,280.00 11/15/2023Shafique ViraniInsiderSell18,000$6.51$117,180.00 11/14/2023Blake BorgesonDirectorSell8,885$6.32$56,153.20 11/14/2023Michael SecoraCFOSell25,000$6.32$158,000.00 (Data available from 1/1/2013 forward) RXRX Insider Trading Activity - Frequently Asked Questions Who is on Recursion Pharmaceuticals's Insider Roster? The list of insiders at Recursion Pharmaceuticals includes Blake Borgeson, Christopher Gibson, Dean Y Li, Michael Secora, Mubadala Investment Co Pjsc, Shafique Virani, Terry-Ann Burrell, Tina Marriott, Tina Marriott Larson, and Zavain Dar. Learn more on insiders at RXRX. What percentage of Recursion Pharmaceuticals stock is owned by insiders? 15.75% of Recursion Pharmaceuticals stock is owned by insiders. Learn more on RXRX's insider holdings. Which Recursion Pharmaceuticals insiders have been buying company stock? The following insider purchased RXRX shares in the last 24 months: Mubadala Investment Co Pjsc ($4,440,853.30). How much insider buying is happening at Recursion Pharmaceuticals? Insiders have purchased a total of 581,017 RXRX shares in the last 24 months for a total of $4,440,853.30 bought. Which Recursion Pharmaceuticals insiders have been selling company stock? The following insiders have sold RXRX shares in the last 24 months: Blake Borgeson ($5,000,727.14), Christopher Gibson ($8,145,291.57), Dean Y Li ($396,140.00), Michael Secora ($3,039,229.92), Shafique Virani ($2,142,358.38), Terry-Ann Burrell ($104,182.25), Tina Marriott ($471,730.00), Tina Marriott Larson ($690,510.00), and Zavain Dar ($181,269.00). How much insider selling is happening at Recursion Pharmaceuticals? Insiders have sold a total of 2,274,334 Recursion Pharmaceuticals shares in the last 24 months for a total of $20,171,438.26 sold. Recursion Pharmaceuticals Key ExecutivesDr. Christopher C. Gibson Ph.D. (Age 41)Co-Founder, CEO & Director Compensation: $806.72kMs. Tina Marriott Larson (Age 49)COO & President Compensation: $702.24kDr. Blake C. Borgeson Ph.D. (Age 42)Co-Founder & Director Compensation: $40kDr. Michael Secora Ph.D. (Age 41)Chief Financial Officer Compensation: $629.78kDr. David J. Mauro M.D. (Age 59)Ph.D., Chief Medical Officer Compensation: $674.74kKevin LeggatVice President of Finance & AccountingMr. Benjamin Mabey M.S. (Age 41)Chief Technology Officer Mr. Jared AllenbachSenior Director of Investor RelationsMr. Nathan HatfieldChief Legal Officer & General CounselMr. Ryan KellyChief Communications Officer More Insider Trading Tools from MarketBeat Related Companies SpringWorks Therapeutics Insider Buying Arcus Biosciences Insider Buying Schrödinger Insider Buying AbCellera Biologics Insider Buying Relay Therapeutics Insider Buying Emergent BioSolutions Insider Buying Absci Insider Buying Viking Therapeutics Insider Buying Elanco Animal Health Insider Buying Blueprint Medicines Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (NASDAQ:RXRX) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredElon Musk’s $30 Billion Trump Bet Pays Off—What’s Next?Elon Musk bet big on Trump's victory, and that gamble has already added over $30 billion to his net worth in a...InvestorPlace | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredBreaking News: Are Trump/Musk Planning an AI Takeover? (Shocking)Now that he is Donald Trump’s right-hand man… You owe it to yourself to see Elon Musk’s big AI prediction f...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Recursion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Recursion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.